India to have strongest global growth in 2019?

4 Dec 2018

Main drivers cited as ‘high-growth domestic market’ and ‘expanding manufacturing exports’.

CPhI & P-MEC India is set to open its doors to more than 40,000 attendees from 120+ countries and 1500 exhibitors, as new analysis shows a massive improvement in India’s global reputation. The India-specific findings of the CPhI Annual Report highlight that India has seen a significant jump across all (six) categories, improving its overall score by a massive 11.06% in a single year.

India to have strongest global growth in 2019?

The country showed the largest gains in terms of perceived ‘quality of API’ and ‘finished product’ manufacturing, proving that industry efforts to align standards more closely with the US and Europe have clearly been noted. But perhaps most significantly, these efforts are also being transferred into reported growth potential for 2019, with India forecast to grow faster than all other major pharma economies, scoring an average of 7.16 – placing it ahead of the US (7.04) and China (6.81). Survey respondents cited India’s ‘high-growth domestic market’ and ‘expanding manufacturing exports’ as the major drivers. The rise in exports growth potential is believed to be in response to concerted reforms by the CDSCO (Central Drugs Standard Control Organisation) and industry quality improvements in the last few years.

Such was the confidence in India’s pharma market, the nation was ranked joint second for ‘overall competitiveness’ of its pharma industry. India scored an average of 6.53, placing it behind only the US (6.98) and level with Germany (6.53). In addition, India saw the largest percentage shift in score for quality of finished formulations, improving by 14.72% since 2017. Most impressively, should the same change be seen in 2019, the country’s reputation for finished product manufacturing will likely see it achieve parity with many European nations (whose scores have remained the same year-on-year) – a dramatic improvement on just a few years ago.

With these hugely positive results as its backdrop, the 12th Annual CPhI & P-MEC India will take place on 12-14 December 2018, alongside India Pharma week (9-14 December). To help further drive forward the market’s growth potential, the event has moved to the Indian capital, taking place at Delhi’s India Expo Centre, Greater Noida, and will return to single venue format. These changes are expected to bring a wider international audience, help more closely integrate vital regulatory pathways into the event's content, and allow an even more diverse cross-pollination of partnerships – meaning visitors can meet with API suppliers, distributors, contract providers and machinery specialists all in the same morning.

In keeping with the international nature of this regional hub, India Pharma Week once again returns for its third edition, with five events running from 9-14 December, including the Pharma Connect Congress, the India Pharma Awards, CEO Roundtable, Networking Evening and Women in Pharma panel amongst others.

“What has been achieved in this country in the last decade is truly remarkable, and it’s clear from the sentiments we hear in the market that we are set for another wave of significant growth and advancement over the next few years. It’s undoubtedly a hugely exciting time for anyone looking to do business in this region. There is notable excitement about CPhI & P-MEC India this year, and the feedback we get from visitors and exhibitors is that they have an extremely confident outlook for 2019 – with all looking for new partners to help drive the country’s next wave of growth. This, coupled with a new single-site location at the India ExpoCentre, will deliver economies of scale and more partnerships and networking opportunities at this event than ever before,” said Cara Turner, Brand Director – Pharma at UBM (part of Informa).

Read More

Related news

Liquid pharmaceuticals in the digital age

Liquid pharmaceuticals in the digital age

30 May 2019

Inspiration, innovation and technical highlights from Bosch Packaging Technolgy's Pharmatag 2019.

Read more 
CPhI China opens with analysis pointing to a surge in growth in 2019

CPhI China opens with analysis pointing to a surge in growth in 2019

28 May 2019

Regulatory reforms and harmonisation reported as key drivers of industry in China.

Read more 
Expert forecasts huge growth in Middle East manufacturing

Expert forecasts huge growth in Middle East manufacturing

16 May 2019

UAE consumers and insurance companies are willing to pay for highest quality drug products.

Read more 
Lessons learned from early EU FMD adopters

Lessons learned from early EU FMD adopters

13 May 2019

Data exchange, investment costs, resources and hardware identified as some of the biggest challenges.

Read more 
Manufacturing growth sees surging demand at CPhI South East Asia

Manufacturing growth sees surging demand at CPhI South East Asia

3 May 2019

Number of visitors seeking a contract manufacturer was extremely high, with multinational corporations increasingly looking for local partners to expedite market access into the wider region.

Read more 
Sirio’s Ayanda launches probiotic softgel

Sirio’s Ayanda launches probiotic softgel

23 Apr 2019

Patent-pending technology is the first ever to enable a softgel capsule to contain both probiotic bacteria and Omega 3 oil.

Read more 
Surge of Indian biosimilars market forecast in 2019

Surge of Indian biosimilars market forecast in 2019

22 Apr 2019

India predicted to be one of the world’s ‘fastest growing bio’ hubs in 2019, fuelled by new biosimilars production.

Read more 
New China-based biotechs fueling growth in manufacturing across China

New China-based biotechs fueling growth in manufacturing across China

9 Apr 2019

New guidelines will see poorer quality manufacturers drop out of the market.

Read more 
BASF launches three new active ingredients derived from the rambutan tree

BASF launches three new active ingredients derived from the rambutan tree

2 Apr 2019

The ingredients are extracted from the first organically certified rambutan gardens in Vietnam.

Read more 
Japanese R&D reinvigorated with international partnerships proliferating

Japanese R&D reinvigorated with international partnerships proliferating

26 Mar 2019

Generics consumption increasing, and the removal of long-list products is opening up funding towards true innovation.

Read more